14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
JRI vs IDE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
IDE Captures Overall Composite Edge (43.8 HOLD vs 39.1 SELL), While JRI Leads 1–0 on Growth & Valuation Pillars
IDE Overall Winner
6-Pillar Tally: JRI 1 – 0 IDE (5 Tie)
Matrix Metrics: JRI 3 – 1 IDE
As of Nov 16, 2026, Voya Infrastructure, Industrials And Materials Fund (IDE) captures the overall head-to-head institutional edge over Nuveen Real Asset Income And Growth Fund (JRI) on higher Unified Composite conviction (43.8/100 HOLD vs. 39.1/100 SELL) after splitting the core matrix 1–3 (led by composite factor balance), while JRI wins 1–0 across the 6-pillar growth and valuation breakdown. JRI trades at $11.09 (N/M Forward P/E, N/A operating margin) versus IDE at $11.75 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: IDE earns the overall head-to-head edge with a stronger Unified Composite Score (43.8/100 HOLD vs. JRI 39.1/100 SELL) and 0.86β · 24% Vol risk profile, whereas JRI leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: JRI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0); meanwhile IDE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JRI vs IDE. Trailing 12-month operating profitability (JRI N/A vs IDE N/A) and valuation multiples (JRI N/M vs IDE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $392.9M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
IDE Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $183.2M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ JRI vs IDE Key Questions & Quantitative Answers
As of Nov 16, 2026, Voya Infrastructure, Industrials And Materials Fund (IDE) captures the overall head-to-head institutional edge over Nuveen Real Asset Income And Growth Fund (JRI) on higher Unified Composite conviction (43.8/100 HOLD vs. 39.1/100 SELL) after splitting the core matrix 1–3 (led by composite factor balance), while JRI wins 1–0 across the 6-pillar growth and valuation breakdown. JRI trades at $11.09 (N/M Forward P/E, N/A operating margin) versus IDE at $11.75 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: IDE earns the overall head-to-head edge with a stronger Unified Composite Score (43.8/100 HOLD vs. JRI 39.1/100 SELL) and 0.86β · 24% Vol risk profile, whereas JRI leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: JRI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.0); meanwhile IDE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JRI leads the Growth & Scale pillar: JRI posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IDE at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JRI generates N/A in USD-normalized revenue versus N/A for IDE. In operating R&D and SG&A reinvestment, JRI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IDE.
JRI and IDE trade at balanced relative valuation multiples. JRI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IDE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JRI (N/A ROE) versus IDE (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, JRI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.51β · 22% Vol realized risk). By comparison, IDE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.86β · 24% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.